Skip to main content

Table 1 Patient characteristics

From: Novel double-filtration plasmapheresis preserves fibrinogen while removing immunoglobulin-G antibodies before ABO blood type-incompatible kidney transplantation

 

cDFPP (n = 23)

nDFPP (n = 12)

p value

Original Disease

IgAN

5

4

.676#

CGN

6

0

ADPKD

5

4

DM

2

1

Unknown or Others

5

3

Duration of pre-transplant dialysis (years)

0.5 (0.0–14.1)

1.2 (0.0–14.2)

.856$

Sex (male:female)

15:8

3:7

.469#

Age at transplant (years)

51 (14–68)

61 (26–67)

.022$

Height (cm)

161.5 (150.1–180.0)

160.0 (148.0–179.5)

.790$

Weight (kg)

59.15 (37.7–78.0)

57.53 (43.75–73.90)

.348$

Body mass index

21.2 (16.0–27.7)

23.3 (16.7–26.7)

.099$

Pre-DFPP data

Hematocrit (%)

34.2 (23.3–47.8)

31.3 (23.3–36.9)

.215$

Total protein (mg/dL)

6.4 (4.9–7.1)

6.2 (5.5–6.6)

.278$

Albumin (mg/dL)

3.6 (3.0–4.3)

3.5 (3.3–3.8)

.517$

Total IgG (mg/dL)

905 (351–1884)

1011 (585–1463)

.948$

Platelet count (/µL)

17.8 (11.4–37.3)

18.6 (11.6–28.4)

.824$

PT-INR

0.98 (0.82–1.20)

1.02 (0.94–1.30)

.179$

APTT (s)

28.1 (23.7–39.6)

29.3 (26.0–42.6)

.840$

Total IgM (mg/dL)

83 (21–220)

54 (21–162)

.122$

Fibrinogen (mg/dL)

224 (129–304)

381 (222–471)

.001$

Anti-ABO IgG antibody titer

1:16 (1:4–1:512)

1:32 (1:8–1:1024)

.493$

Anti-ABO IgM antibody titer

1:32 (1:8–1:128)

1:12 (1:4–1:16)

.001$

  1. ADPKD Autosomal-dominant polycystic kidney disease, APTT activated partial thromboplastin time, CGN chronic glomerulonephritis, DM diabetes mellitus, IgAN IgA nephropathy, PT-INR international normalized ratio of prothrombin time. #: chi-squared test, $: Wilcoxon rank-sum test